中科微点-全球专利检索

  1. Login
  2. Sign Up
Invention Grant
US08357362B2 Treating non-hematopoietic cancer with interleukin 6 有权
用白细胞介素6治疗非造血性癌症

  • Patent Title: Treating non-hematopoietic cancer with interleukin 6
  • Patent Title (中): 用白细胞介素6治疗非造血性癌症
  • Application No.: US13490870
    Application Date: 2012-06-07
  • Publication No.: US08357362B2
    Publication Date: 2013-01-22
  • Inventor: Dawei Xu
  • Applicant: Dawei Xu
  • Applicant Address: US IN Indianapolis
  • Assignee: Bionewpath LLC
  • Current Assignee: Bionewpath LLC
  • Current Assignee Address: US IN Indianapolis
  • Agency: Wolf, Greenfield & Sacks, P.C.
  • Main IPC: A61K38/20
  • IPC: A61K38/20
Treating non-hematopoietic cancer with interleukin 6
Abstract:
Use of IL-6 for treating non-hematopoietic cancers, e.g., gp130-negative cancers. Also disclosed is a method for identifying a cancer patient suitable for the IL-6 treatment.
Abstract(Chinese):

使用IL-6治疗非造血性癌症，例如gp130阴性癌症。 还公开了一种鉴定适合于IL-6治疗的癌症患者的方法。

Public/Granted literature
Information query
Espacenet
Patent Agency Ranking
0/0